Antineoplaston A10 is primarily researched for its potential application in cancer therapy. It is explored as a treatment for various types of cancers, including brain tumors, breast cancer, and liver cancer. The compound is believed to work by targeting cancer cells and inducing apoptosis, thereby inhibiting tumor growth. Clinical trials and studies have been conducted to evaluate its efficacy and safety, particularly in patients with advanced or treatment-resistant cancers. While it shows promise, further research is needed to fully understand its mechanisms and establish its role in modern oncology.